Search - tctmd.com

Displaying 681 - 700 of 970

Sort: Relevancy | Date

Presentation TCT 2015

What, if Any, Is the Role for LMWH and GP IIb/IIIa Inhibitors in ACS or During PCI?

Presenter: John A. Bittl, Robert A. Harrington, Jorge F. Saucedo

October 12, 2015

Presentation TCT 2015

Bivalirudin Pearls: Necessity With Radial Access, Infusion Dose and Duration, Use in CKD, and More

Presenter: John A. Bittl, Robert A. Harrington, Philippe Gabriel Steg

October 12, 2015

Presentation TCT 2015

Bivalirudin vs Heparin in ACS: The New Data MATRIX Antithrombin Results

Presenter: John A. Bittl, Robert A. Harrington, Marco Valgimigli

October 12, 2015

Presentation TCT 2015

iFR and Pd/Pa to Guide PCI in Diffuse and Multivessel CAD: A Case-Based Review

Presenter: Habib Samady, Justin E. Davies

October 12, 2015

News Conference News TCT 2015

Robotic Systems to Play Greater Role in Cath Lab of the Future

Todd Neale

October 12, 2015

News Conference News TCT 2015

Mortality Increasing in Elderly PCI Patients

October 12, 2015

News Conference News TCT 2015

Featured Lecture Calls for Integration of New Technologies to Improve Cath Lab Care

Yael L. Maxwell

October 12, 2015

News Conference News TCT 2015

DISCOVER Registry: Positive Results Seen for Next-Generation TAVR Device at 1 Year

October 12, 2015

News Conference News TCT 2015

DAPT Study Subanalysis Focuses on EES Subgroup

October 12, 2015

Presentation TCT 2015

PCI for Multivessel Disease in the CABG Candidate: Should We Follow the Guidelines? With Case Examples

Presenter: Thomas Engstroem, Manh-Hung Pham, Nhan Thanh Vo, Minh Vo

October 11, 2015

Presentation TCT 2015

PCI for Multivessel Disease With CTO: When and How? With Case Examples

Presenter: Thomas Engstroem, Manh-Hung Pham, Nhan Thanh Vo, Cheol Woong Yu

October 11, 2015

Presentation TCT 2015

A Practical Stenting Issue in Multivessel Disease: When and Where to Stop? With Case Examples

Presenter: Thomas Engstroem, Manh-Hung Pham, Nhan Thanh Vo, Kevin Bainey

October 11, 2015

Presentation TCT 2015

How to Apply Physiology-Guided PCI for MVD

Presenter: Thomas Engstroem, Manh-Hung Pham, Chang-Wook Nam

October 11, 2015

Presentation TCT 2015

One-Stage vs Delayed PCI for Nonculprit Lesion in Patients With AMI and Multivessel Disease

Presenter: Thomas Engstroem, Manh-Hung Pham, Henning Kelbæk

October 11, 2015

Presentation TCT 2015

Complete vs Incomplete Revascularization

Presenter: Thomas Engstroem, Manh-Hung Pham, David A. Wood

October 11, 2015

Presentation TCT 2015

Role of Bioresorbable Vascular Scaffolds in a Hybrid Revascularization Strategy

Presenter: Taehoon Ahn, Robert C. Welsh, Quang Ngoc Nguyen

October 11, 2015

Presentation TCT 2015

Hybrid Revascularization Strategy for AMI Patients: How to Apply

Presenter: Taehoon Ahn, Robert C. Welsh, Christian Juhl Terkelsen

October 11, 2015

Presentation TCT 2015

The Case for Hybrid Revascularization: Combining the LIMA With the LAD With Stenting of Non-LAD Lesions

Presenter: Taehoon Ahn, Robert C. Welsh, Leif Thuesen

October 11, 2015

Presentation TCT 2015

PCI May Be Considered in Challenging Patients With Triple-Vessel Disease

Presenter: Taehoon Ahn, Robert C. Welsh, Young-Hak Kim

October 11, 2015

Presentation TCT 2015

Outcomes Have Always Been Better With CABG

Presenter: Taehoon Ahn, Robert C. Welsh, Samer Mansour

October 11, 2015

Advertisement

What, if Any, Is the Role for LMWH and GP IIb/IIIa Inhibitors in ACS or During PCI?

Bivalirudin Pearls: Necessity With Radial Access, Infusion Dose and Duration, Use in CKD, and More

Bivalirudin vs Heparin in ACS: The New Data MATRIX Antithrombin Results

iFR and Pd/Pa to Guide PCI in Diffuse and Multivessel CAD: A Case-Based Review

Robotic Systems to Play Greater Role in Cath Lab of the Future

Mortality Increasing in Elderly PCI Patients

Featured Lecture Calls for Integration of New Technologies to Improve Cath Lab Care

DISCOVER Registry: Positive Results Seen for Next-Generation TAVR Device at 1 Year

DAPT Study Subanalysis Focuses on EES Subgroup

PCI for Multivessel Disease in the CABG Candidate: Should We Follow the Guidelines? With Case Examples

PCI for Multivessel Disease With CTO: When and How? With Case Examples

A Practical Stenting Issue in Multivessel Disease: When and Where to Stop? With Case Examples

How to Apply Physiology-Guided PCI for MVD

One-Stage vs Delayed PCI for Nonculprit Lesion in Patients With AMI and Multivessel Disease

Complete vs Incomplete Revascularization

Role of Bioresorbable Vascular Scaffolds in a Hybrid Revascularization Strategy

Hybrid Revascularization Strategy for AMI Patients: How to Apply

The Case for Hybrid Revascularization: Combining the LIMA With the LAD With Stenting of Non-LAD Lesions

PCI May Be Considered in Challenging Patients With Triple-Vessel Disease

Outcomes Have Always Been Better With CABG

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content